Results 161 to 170 of about 21,454 (214)

Vascular transcriptional and metabolic changes precede progressive intrarenal microvascular rarefaction in autosomal dominant polycystic kidney disease. [PDF]

Am J Physiol Renal Physiol
Yilmaz G, Singha SK, Savaliya B, Abdelfattah A, Elsekaily W, Xu X, Zhang Y, Hanna C, Hogan MC, Chade AR, Eirin A, Irazabal MV.   +11 more
europepmc   +1 more source

Recurrent obturator hernia in a patient with autosomal dominant polycystic kidney disease undergoing peritoneal dialysis: a case report. [PDF]

CEN Case Rep
Okumura K, Kawanishi T, Abe Y, Tanami H, Sugano N.   +4 more
europepmc   +1 more source

Validation of Combining Total Kidney Volume and Kidney Failure Risk Equation in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney Int Rep
Bevilacqua M, Guan M, Romann A, Er L, Shao T, Farah M, Elliott MD.   +6 more
europepmc   +1 more source

Efficacy and safety of tolvaptan in rapidly progressing autosomal dominant polycystic kidney disease: a single-center, prospective, single-arm study. [PDF]

Transl Androl Urol
Zhou L, Li W.
europepmc   +1 more source

GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease. [PDF]

J Med Chem
Wu SS, Hung PY, Yeh TY, Lin PJ, Chern JW, Yu CW.   +5 more
europepmc   +1 more source

Abnormal purinergic signaling contributes to development of renal cysts in autosomal dominant polycystic kidney disease. [PDF]

Purinergic Signal
Ivanov V, Wu A, Crocetti L, Meng Z, Shrestha-Maskey P, Liao TD, Adrianto I, Guerrini G, Ortiz PA, Pavlov TS.   +9 more
europepmc   +1 more source

Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study. [PDF]

Front Med (Lausanne)
Zhou L, Li W.
europepmc   +1 more source

Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review. [PDF]

Ren Fail
Borghol AH, Azooz M, Bou Antoun MT, Souvalian L, Shami B, Mina J, Munairdjy Debeh FG, Ghanem A, Sandouk H, Rangarajan V, Hanna D, Naranjo CD, Drexler Y, Norouzi S, Noruzi A, Salih M, Klett DE, Porter IE, Dahl NK, Chebib FT.   +19 more
europepmc   +1 more source